← Leaderboards
Lisa Morici
Tulane University Of Louisiana
$8,296,098
Attributed
$8,296,098
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2019–22$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
Funding mix
By agency
NIH$8,296,098 · 1
By mechanism
N01$8,296,098 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Mario Tomas Philipp$11,469,177
- Ramesh Ramamoorthy$1,682,297
- Lu Qi$19,868,722
- Lydia Bazzano$16,911,507
- William C. Wimley$6,017,003
Others in their field
Other Emerging Leaders on “Adjuvant”
- Ted Ross · University Of Georgia$68,763,143
- Jay Evans · University Of Montana$43,101,450
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Aaron Esser-Kahn · University Of Chicago$13,698,058
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$10,000,000
- Garcia-Sastre Adolfo · Icahn School Of Medicine At Mount Sinai$8,560,974
Research focus
AdjuvantAttenuatedBurkholderiaLipid AMembraneVaccinesVesicleImmunologicsPathogenInvestigationHuman DiseaseBordetella PertussisLicensureSupport ContractsImmunogenicityIxodesUnvaccinatedContractorLyme Disease VaccinesVaccine AdjuvantNonhuman PrimatePreparationPreventSafety
Grant awards (4)
Adjuvant development within the context of a vaccine to protect against B. pertussis$1,709,700
N01 · FY2022 · AI · contact PI
Evaluation of an OMV-adjuvanted Chimeritrope Vaccine against Lyme Disease$1,274,999
N01 · FY2022 · AI · contact PI
Adjuvant development within the context of a vaccine to protect against B. pertussis$1,977,192
N01 · FY2021 · AI · contact PI
Adjuvant development within the context of a vaccine to protect against B. pertussis$3,334,207
N01 · FY2019 · AI · contact PI